Ed PaganiTitle: Associate Director, Health Technologies
Ed Pagani, PhD, works with faculty and researchers at the University of Michigan School of Medicine to promote, protect and commercialize new discoveries. Ed gained extensive licensing and R&D experience in the pharmaceutical and medical device industries as Assistant Director, Cardiopulmonary Pharmacology, at Sterling Winthrop; Senior Director, Strategic Alliance at Pfizer; and Vice President, Molecular Diagnostics, at Beckman Coulter. Immediately prior to joining the Office of Technology Transfer, Ed held the position of CEO, North America at LGC, LTD, a private, equity-backed company headquartered in London, England.
Ed holds an AB degree from Columbia University, a PhD in Physiology from the University of Cincinnati College of Medicine, and completed 3 years of post-doctoral training at Harvard Medical School/Brigham & Women’s Hospital.